Pure Global

Family Treasure Qingqingbao Blood glucose/total cholesterol/uric acid monitoring system - Taiwan Registration 08a150cd0742fc9b3afb88c8f7455f35

Access comprehensive regulatory information for Family Treasure Qingqingbao Blood glucose/total cholesterol/uric acid monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 08a150cd0742fc9b3afb88c8f7455f35 and manufactured by Yuxin Biotechnology Co., Ltd.;; IAC Corporation. The authorized representative in Taiwan is INVENTEC APPLIANCES CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
08a150cd0742fc9b3afb88c8f7455f35
Registration Details
Taiwan FDA Registration: 08a150cd0742fc9b3afb88c8f7455f35
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Family Treasure Qingqingbao Blood glucose/total cholesterol/uric acid monitoring system
TW: ๅ…จๅฎถๅฏถ ๆธ…ๆธ…ๅฏถ ่ก€็ณ–/็ธฝ่†ฝๅ›บ้†‡/ๅฐฟ้…ธ ็›ฃๆธฌ็ณป็ตฑ
Risk Class 2

Registration Details

08a150cd0742fc9b3afb88c8f7455f35

Company Information

Taiwan, Province of China

Product Details

This product is for in vitro testing only and needs to be used with a smartphone with the Family Treasure mobile app installed. This product uses fresh fingertip microvascular whole blood to quantify blood sugar, total cholesterol and uric acid. This product can be used by self-testing and healthcare professionals, but is not intended for testing of newborns.

A Clinical chemistry and clinical toxicology

A.1660 Quality control materials (analytical and non-analytical); A.1345 Glucose Test System;; A.1175 Cholesterol (Total) Testing System

Domestic;; Contract manufacturing

Dates and Status

Dec 11, 2019

Dec 11, 2029